Taking care of yourself shouldn't be complicated. We talk to the experts for practical advice to live a long and healthy life, based on science. Updated every time Life Kit posts an episode on health ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Everyone needs a little help being a human. From sleep to saving money to parenting and more, host Marielle Segarra talks to experts to get the best advice out there. Life Kit is here to help you get ...

Senior Film Writer Borys Kit breaks the latest scoops on movies, from acquisitions to castings to the dreaded and they-wish-he-wouldn’t-write-about reshoots (ahem, “additional photography”). He ...

Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after an androgen receptor pathway inhibitor. Tanya B. Dorff, MD, medical oncologist and ...

The best at-home COVID-19 tests are FDA-authorized, easy to use, accurate, quick, and can also detect flu viruses. Lauren Paige Richeson is an Editor at Health, where she’s been writing, editing, and ...

Kohei Shitara, MD, discusses CLDN18.2-guided therapy, nivolumab plus zolbetuximab, and toxicity management in advanced gastric and gastroesophageal cancers. New research presented at ASCO GI positions ...

This article was updated with new products and information in October 2026. Preparedness is about more than just keeping your vehicle in decent shape for weekend drives or optimizing your fuel ...

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO’s flagship Journal of Clinical Oncology. Host Dr. Davide Soldato ...

On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its new ...

Still looking? See more results on Wirecutter. We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Signe Brewster and James Austin ...

A statistically significant OS benefit was observed with relacorilant plus nab-paclitaxel for patients with platinum-resistant ovarian cancer. The 48-month OS rate was 78.6% with pembrolizumab vs 60.4 ...